Mochida Pharmaceutical Revenue

Mochida Pharmaceutical had revenue of 32.50B JPY in the quarter ending December 31, 2025, with 9.67% growth. This brings the company's revenue in the last twelve months to 111.92B, up 6.18% year-over-year. In the fiscal year ending March 31, 2025, Mochida Pharmaceutical had annual revenue of 105.16B with 2.21% growth.

Revenue (ttm)

111.92B

Revenue Growth

+6.18%

P/S Ratio

1.19

Revenue / Employee

74.21M

Employees

1,508

Market Cap

132.76B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	105.16B	2.27B	2.21%
Mar 31, 2024	102.89B	-376.00M	-0.36%
Mar 31, 2023	103.26B	-6.92B	-6.28%
Mar 31, 2022	110.18B	7.18B	6.98%
Mar 31, 2021	103.00B	1.20B	1.17%
Mar 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Toho Holdings	1.53T
Towa Pharmaceutical	266.67B
Sawai Group Holdings	200.00B
Tsumura & Co.	189.50B
Nippon Shinyaku	166.05B
KYORIN Pharmaceutical	133.26B
Kissei Pharmaceutical	95.29B
Zeria Pharmaceutical	86.62B

Revenue Rankings